|
PAIP2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.562000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.363970E-01 |
| Normal-vs-Stage2 |
2.803600E-01 |
| Normal-vs-Stage3 |
4.146200E-01 |
| Normal-vs-Stage4 |
1.019600E-02 |
| Stage1-vs-Stage2 |
4.912000E-01 |
| Stage1-vs-Stage3 |
9.383600E-01 |
| Stage1-vs-Stage4 |
7.247600E-04 |
| Stage2-vs-Stage3 |
6.453800E-01 |
| Stage2-vs-Stage4 |
5.792000E-02 |
| Stage3-vs-Stage4 |
4.474200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.565800E-02 |
| Normal-vs-AfricanAmerican |
4.120400E-01 |
| Normal-vs-Asian |
7.365600E-01 |
| Caucasian-vs-AfricanAmerican |
3.397200E-01 |
| Caucasian-vs-Asian |
9.523200E-01 |
| AfricanAmerican-vs-Asian |
8.344400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.191990E-01 |
| Normal-vs-Female |
7.715800E-02 |
| Male-vs-Female |
4.461400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.072600E-01 |
| Normal-vs-Extreme_Weight |
8.365400E-01 |
| Normal-vs-Obese |
2.289000E-01 |
| Normal-vs-Extreme_Obese |
9.923500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.955800E-01 |
| Normal_Weight-vs-Obese |
6.804200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.505020E-01 |
| Extreme_Weight-vs-Obese |
2.908600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.110230E-01 |
| Obese-vs-Extreme_Obese |
3.067000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.066500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.106980E-01 |
| Normal-vs-Age(61-80Yrs) |
8.245800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.580420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.217700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.662100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.532000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.102200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.850000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.115000E-01 |
| Normal-VS-Type2 PRCC |
1.582260E-02 |
| Normal-VS-KIRP CIMP |
7.584000E-03 |
| Normal-VS-Unclassified PRCC |
5.596300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.652200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.915700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.473900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.189200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.042400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.444750E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.504400E-01 |
| Normal-vs-N1 |
8.314600E-01 |
| Normal-vs-N2 |
8.972000E-01 |
| N0-vs-N1 |
6.973000E-01 |
| N0-vs-N2 |
9.364600E-01 |
| N1-vs-N2 |
8.660800E-01 |
|
|
